<DOC>
	<DOCNO>NCT02399189</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety chemotherapy MT-R follow autologous stem cell transplantation newly-diagnosed primary central nervous system lymphoma .</brief_summary>
	<brief_title>MT-R Followed Autologous Stem Cells Transplantation Newly-diagnosed Primary Central Nervous System Lymphoma</brief_title>
	<detailed_description>It 's single center , single arm , prospective clinical trial . Patients young 65 year old primary central nervous system lymphoma receive four cycle chemotherapy rituximab plus high-dose methotrexate temozolomide induction therapy , receive consolidation therapy autologous stem cell transplant condition regimen Carmustine plus thiotepa .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<criteria>primary central nervous system diffuse large Bcell lymphoma histologically confirm brain biopsy ECOG 02 Absence systemic disease evaluate chestabdomenpelvis CT scan Leucocytes &gt; 3.500/mm3 , platelet &gt; 130.000/mm3 , Bilirubin &lt; 2 mg , transaminases &lt; 2.5 N ) , creatinine &lt; 150 Î¼M/l , creatinine clearance &gt; 50 ml/min/1.73m2 Age 1865 year Negative HIV test Signature inform consent prior chemotherapy primary central nervous system lymphoma presence another cancer ( except basal cell carcinoma skin cervical carcinoma situ ) systemic lymphoma ( outside CNS ) Isolated ocular lymphoma Immunosuppressed patient ( HIV , use immunosuppressor ) Other uncontrolled progressive disease compromise shotterm survival Severe renal hepatic disease Patients legally cover French Social Security Inability swallow medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Primary central nervous system lymphoma</keyword>
	<keyword>rituximab</keyword>
	<keyword>Methotrexate Temozolomide</keyword>
	<keyword>autologous stem cell transplantation</keyword>
	<keyword>Carmustine thiotepa</keyword>
</DOC>